Normal view MARC view ISBD view

Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Zweck, Elric

Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. [electronic resource] - The New England journal of medicine 11 2019 - 2075-2076 p. digital

Publication Type: Letter; Comment

ISSN: 1533-4406

Standard No.: 10.1056/NEJMc1913157 doi

Subjects--Topical Terms:
Diabetes Mellitus, Type 2
Glucagon-Like Peptides
Humans
Hypoglycemic Agents

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)